Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...

We recently compiled a list of the 12 Safest Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...

Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Wells Fargo lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,000 and keeps an Overweight rating on the shares. The firm ...

Eli Lilly And Co (LLY) stock saw a modest uptick, ending the day at $808.17 which represents a slight increase of $22.76 or 2.90% from the prior close of $785.41. The stock opened at $780.91 and ...

Shares of Tectonic plummeted 41% Tuesday following news that a similar drug developed by Eli Lilly (NYSE: LLY) for chronic ...

For Hoosiers seeking a fresh start or a pathway to a fulfilling career, the Lilly Scholars at Ivy Tech scholarships offer a ...

IUSG follows a growth-oriented strategy but lags behind peers due to conservative allocations in key growth sectors like ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.